News

Verdiva Bio to Present New Data Highlighting Once-Weekly Potential of Its Investigational Oral Obesity Candidates at the ADA 85th Scientific Sessions
Verdiva Bio Limited ("Verdiva" or "the Company") a clinical-stage biopharmaceutical company focused on developing innovative ...
Skye Bioscience to Present Expanded Preclinical CB1 Antibody Data at the American Diabetes Association’s 85th Scientific Sessions
Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on unlocking new therapeutic ...
TMCnet9d
T1D Exchange Announces 13 Real-World Data Presentations and Posters at the American Diabetes Association (ADA) 85th Scientific Sessions
New study examines benefits of continuous glucose monitoring (CGM) in people with type 2 diabetes (T2D) using glucagon-like ...
Hosted on MSN11d
Ascletis presents new data on ASC30 and ASC47 at ADA 2025
HONG KONG, June 9, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary ... Poster Hall (Hall F1) Presentation Time: Sunday Jun 22, ...
Zacks Small Cap Research on MSN18d
IMNN: Momentum Continues with Presentations at ASCO and ESMO Gynaecological Cancers…
IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Momentum Continues with Presentations at ASCO and ESMO Imunon, Inc.